NextGen 2024: Refractory SJIA & MAS Session Part 8

NextGen 2024: Refractory SJIA & MAS Session Part 8

@SJIA_Foundation
@SJIA_Foundation
8 Followers
2 weeks ago 67

NextGen 2024: Refractory SJIA & MAS Session Part 8

@SJIA_Foundation2 weeks ago

Treating Refractory Adult Still's Patients
Bruno Fautrel, MD PhD
Sorbonne University - Assistance…
1/10
• Financial interests
– None
• Permanent links
– None
• Interventions
– AbbVie, Amgen, Biogen,…
2/10
Adult Still's disease (MSA)
• Still's disease in children
– Systemic form of AJI (FS-AJI) 
Syste…
3/10
« Refractory » Adult Still’s Patients
• Refractory or « D2T » : lack of definition
• Several opti…
4/10
Active Active and Severe
« Very active » Still’s disease
Auto-inflammatoiry condition
• IL-18 10…
5/10
EULAR / PReS Recommendations
LoE Strength % 
Agreemt
10
MAS should be considered in patients wi…
6/10
For non-inflammatory D2T patients
Patient 
living with 
Still’s 
disease
7/10
Conclusion
8/10
Conclusion 
EULAR / PReS Recommendations
LoE Strength % 
Agreemt
14
Difficult-to-treat patient…
9/10
Thank you 
• Merci!
10/10


  • Previous
  • Next
  • f Fullscreen
  • esc Exit Fullscreen
@SJIA_Foundation

Share

NextGen 2024: Refractory SJIA & MAS Session Part 8

Embed code


Swipe LEFT
to view Related

Scroll DOWN
to read doc

This website uses cookies to improve your experience. By using this site, you consent to the use of cookies.

Login

OR

Forgot password?

Don't have an account? Sign Up